Use of antipyretics to reduce flu-related fever
July 12, 2011
MEDIA STATEMENT
Use of
antipyretics to reduce flu-related fever
The New Zealand Self-Medication Industry Association (SMI), the industry body representing non-prescription consumer healthcare products, said today it was aware of a recommendation by the Wellington-based Medical Research Institute that antipyretics, such as paracetamol, ibuprofen and aspirin, not be used to reduce flu-related fever.
“We have
only just received this information and, as the Institute
itself said, there was insufficient evidence for the
Ministry of Health to change its current position on these
products. It’s important people do not overreact and stop
using antipyretics altogether.
Paracetamol and ibuprofen, for example, are well recognized for the relief of pain,” commented SMI executive director Tim Roper.
“Fever
management guidelines highlight that it is important to
treat the patient and not the thermometer - SMI and its
members endorse this approach. We are confident that if
this approach is used, that these medicines can be used
safely.
“Nevertheless, our members welcome the
opportunity to work with Medsafe to discuss any matters that
may arise, after the Ministry has reviewed the new
information.”
ends
Early Childhood New Zealand: Budget 2026 Must Protect The Future Of Quality Early Childhood Education
Creative New Zealand: Aotearoa Manu Take World Art Stage As 61st Venice Biennale Opens
Country Music Honours: 2026 Country Music Honours Finalists Announced
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future
Dry July: Thousands Set To Go Alcohol Free This July As Cancer Diagnoses Continue To Rise Across Aotearoa